We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Women's Healthcare Market Flourishes, But Innovation Still Needed

By HospiMedica International staff writers
Posted on 05 Mar 2009
Twenty-five years of unprecedented medical advancements and global recognition has increased focus on the health of women worldwide, signifying a growing market for treatments to cure those diseases that affect women most. Now thriving, the total women's healthcare market is poised to exceed US$97 billion by 2013, according to a recent report.

The estimates were compiled by medical market research publisher Kalorama Information (New York, NY, USA). Kalorama's analysts looked at disorders that affect the female reproductive system and other disorders where there was at least a 70% preponderance of women affected by the condition. The 2013 forecasted figure equates to a compound annual growth rate (CAGR) of approximately 9% for the period beginning in 2008, when the women's healthcare market reached almost $64 billion.

Market strength is currently attributed to several industry segments, including rheumatoid arthritis treatments in the autoimmune disease segment, antivirals in the gynecologic infections and sexually transmitted disease (STD) segment, and treatments for osteoporosis. Sustained future growth will be supported by the aging of women globally and the expected increase in product demand as new product approvals and introductions provide a greater variety of options.

In spite of the clear advancement in women's healthcare, the need for continued innovation is palpable. Kalorama Information expects the next 10 years to progressively reflect significant changes in the market for new treatments combating women's health disorders, due largely to the growing empowerment of female consumers and the rising demand for safe and effective medications and lifestyle drugs.

"There's room for improvement,” noted Bruce Carlson, publisher of Kalorama Information. "Current research has opened potential breakthroughs, creating a new era of treatment possibilities. However, in many of the disorders routinely impacting women, current product offerings are simply mediocre.”

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of research services.

Related Links:

Kalorama Information




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Mobile Power Procedure Chair
LeMans P360
New
Mobile Barrier
Tilted Mobile Leaded Barrier

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024